You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The firm earlier this week also filed a prospectus for the sale of nearly 2 million shares of common stock that may be reoffered or resold from time to time by certain selling stockholders.
The California-based genetic testing firm said its new lab will be able to process 20,000 tests per day and will initially focus on COVID-19 testing.
The coverage comes after the women's health diagnostics firm went public last month, seeking up to $100 million in the offering.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.